Citations

Mayo Clinic

Clear

259 citation(s) found for "Ma, Rui".

A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).
Qin, Rui , Sicotte, Hugues , Carlson, Rachel E. , Tan, Winston , Jiménez, Rafael E. , Wang, Liewei , Eckel‐Passow, Jeanette E. , Costello, Brian A. , Pitot, Henry C., Dronca, Roxana , Wu, Kevin J. , Moynihan, Timothy J. , Atwell, Thomas D. , McMenomy, Brendan P., Kohli, Manish , Wang, Liguo , Quevedo, Fernando , Ho, Thai H. , Bryce, Alan H. , Dehm, Scott M.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 5056-5056

10.1200/jco.2015.33.15_suppl.5056 Get It

Association of germline variation with androgen ablation (AA) failure in advanced hormone-sensitive prostate cancer (HSPC).
Zhang, Ben Yiming, Riska, Shaun M., Lee, Adam M , Quevedo, Fernando , Costello, Brian A. , Pitot, Henry C., Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Silva, Fernando Eduardo Calais Da, Kochuparambil, Samith T. , Mahoney, Douglas W. , McDonnell, Shannon K. , Lee, Adam M. , Ribeiro, Ricardo , Medeiros, Rui , Cerhan, James R. , Kohli, Manish

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16117-e16117

10.1200/jco.2015.33.15_suppl.e16117 Get It

Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.
Zhang, Ben Yiming, Riska, Shaun M., Ribeiro, Ricardo , Medeiros, Rui , Monteiro, Cátia, Nogueira, Augusto, Maurício, Joaquina, Fraga, Avelino , Calais-Da-Silva, Fernando, Costello, Brian A. , Dronca, Roxana , Pitot, Henry C., Moynihan, Timothy J. , Quevedo, Fernando , Mahoney, Douglas W. , Cerhan, James R. , Kohli, Manish

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e16114-e16114

10.1200/jco.2015.33.15_suppl.e16114 Get It

Quality of life analysis of NCCTG N0877 (Alliance): Phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM).
Qin, Rui , Tan, Angelina D., Sloan, Jeff A. , Lesser, Glenn J. , Anderson, S. Keith , Johnson, Derek R. , Laack, Nadia N.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e17715-e17715

10.1200/jco.2015.33.15_suppl.e17715 Get It

Effects of pazopanib therapy on mean corpuscular volume in patients enrolled in MC1112: Analysis of correlation with time to disease progression in solid tumors.
Burton, Jill K., Qin, Rui , Erlichman, Charles , Harris, Pamela Jo , Bible, Keith C. , Kumar, Aditi , Suman, Vera J. , Haluska, Paul

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e13596-e13596

10.1200/jco.2015.33.15_suppl.e13596 Get It

Outcomes of sinonasal inverted papilloma resection by surgical approach: an updated systematic review and meta‐analysis
Peng, Rui, Thamboo, Andrew , Zhou, Bing , Hwang, Peter H. , Hwang, Peter H , Peng, Rui, Choby, Garret , Ma, Yifei

International Forum of Allergy & Rhinology | February 12, 2019 | Volume: 9 | Issue: 6 | Pages: 573-581

10.1002/alr.22305 | PMID 30748098 Get It

Background Selecting the optimal surgical approach for resection of sinonasal inverted papilloma (SIP) remains a challenge, with endoscopic, external, and combined approaches being utilized. This systematic review was conducted as an update to a 2006 systematic review to determine the preferred surgical approach for tumor control. Methods The study protocol was developed a priori following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) process. Data were collected and outcomes were analyzed according to surgical approach and sites of tumor involvement. Results A total of 96 papers and 4134 SIP patients were included. The overall recurrence rate was 12.80% (322/2515) for the endoscopic approach group, 16.58% (182/1098) for the external approach group, and 12.60% (65/516) for the combined approach group. Meta‐analysis by random effects model showed that the summarized risk ratio (RR) of recurrence was 0.61 (95% confidence interval [CI], 0.44 to 0.85, p = 0.003), I 2 = 37.95% for the endoscopic vs external approach; 0.98 (95% CI, 0.69 to 1.39, p = 0.901), I 2 = 9.06% for the endoscopic vs combined approach; 1.61 (95% CI, 1.06 to 2.43, p = 0.025), I 2 = 0.00% for the external vs combined approach. After adjusting for publication bias, the adjusted RRs were 0.66 ( p = 0.014) for endoscopic vs external; 0.99 ( p = 0.955) for endoscopic vs combined; and 1.33 ( p = 0.224) for external vs combined. Conclusion An enlarging and maturing body of literature continues to indicate that endoscopic approaches result in significantly lower recurrence rates than open approaches for surgical resection of SIP.
Neuroendocrine differentiation patterns in metastases from advanced prostate cancer.
Jiménez, Rafael E. , Nandy, Debashis, Qin, Rui , Carlson, Rachel E. , Tan, Winston , Kohli, Manish , Kohli, Manish

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 5085-5085

10.1200/jco.2014.32.15_suppl.5085 Get It

Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
Costello, Brian A. , Tan, Winston , Leibovich, Bradley C. , Castle, Erik P., Parker, Alexander S. , Dronca, Roxana , Qin, Rui , Ho, Thai H. , Kohli, Manish

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS4606-TPS4606

10.1200/jco.2014.32.15_suppl.tps4606 Get It

Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
Kim, George P., Qin, Rui , Lensing, Janet L., Wright, John Joseph, Erlichman, Charles , Grothey, Axel, Hubbard, Joleen M. , Borad, Mitesh J.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 2539-2539

10.1200/jco.2014.32.15_suppl.2539 Get It

NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Park, Haeseong , Qin, Rui , Atherton, Pamela J. , Barton, Debra L. , Sturtz, Keren , Dakhil, Shaker R. , Anderson, Daniel M. , Stella, Philip J., Puttabasavaiah, Suneetha, Le‐Lindqwister, Nguyet, Padula, Gilbert D. A. , Loprinzi, Charles L. , Smith, Thomas J.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 9508-9508

10.1200/jco.2014.32.15_suppl.9508 Get It